Living bone allotransplants survive by surgical angiogenesis alone: development of a novel method of composite tissue allotransplantation.
BACKGROUND
Segmental bone defects pose reconstructive challenges. Composite tissue allotransplantation offers a potential solution but requires long-term immunosuppression with attendant health risks. This study demonstrates a novel method of composite-tissue allotransplantation, permitting long-term drug-free survival, with use of therapeutic angiogenesis of autogenous vessels to maintain circulation.


METHODS
Ninety-three rats underwent femoral allotransplantation, isotransplantation, or allografting. Group-1 femora were transplanted across a major histocompatibility complex barrier, with microsurgical pedicle anastomoses. The contralateral saphenous artery and vein (termed the AV bundle) of the recipient animal were implanted within the medullary canal to allow development of an autogenous circulation. In Group 2, allotransplantation was also performed, but with AV bundle ligation. Group 3 bones were frozen allografts rather than composite-tissue allotransplantation femora, and Group 4 bones were isotransplants. Paired comparison allowed evaluation of AV bundle effect, bone allogenicity (isogeneic or allogeneic), and initial circulation and viability (allotransplant versus allograft). Two weeks of immunosuppression therapy maintained blood flow initially, during development of a neoangiogenic autogenous blood supply from the AV bundle in patent groups. At eighteen weeks, skin grafts from donor, recipient, and third-party rats were tested for immunocompetence and donor-specific tolerance. At twenty-one weeks, bone circulation was quantified and new bone formation was measured.


RESULTS
Final circulatory status depended on both the initial viability of the graft and the successful development of neoangiogenic circulation. Median cortical blood flow was highest in Group 1 (4.6 mL/min/100 g), intermediate in Group 4 isotransplants (0.4 mL/min/100 g), and absent in others. Capillary proliferation and new bone formation were generally highest in allotransplants (15.0%, 6.4 μm³/μm²/yr) and isotransplants with patent AV bundles (16.6%, 50.3 μm³/μm²/yr) and less in allotransplants with ligated AV bundles (4.4%, 0.0 μm³/μm²/yr) or allografts (8.1%, 24.1 μm³/μm²/yr). Donor and third-party-type skin grafts were rejected, indicating immunocompetence without donor-specific tolerance.


CONCLUSIONS
In the rat model, microvascular allogeneic bone transplantation in combination with short-term immunosuppression and AV bundle implantation creates an autogenous neoangiogenic circulation, permitting long-term allotransplant survival with measurable blood flow.
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA. bishop.allen@mayo.edu
Mikko
M
Larsen
Michael
M
Pelzer
Patricia F
PF
Friedrich
Christina M
CM
Wood
Allen T
AT
Bishop
D000818:Animals; D001158:Arteries / Q000601:surgery; D016025:Bone Transplantation / Q000379:methods*; D001842:Bone and Bones / Q000098:blood supply; D005260:Female; D005269:Femur / Q000098:blood supply / Q000601:surgery; D007108:Immune Tolerance / Q000502:physiology; D007121:Immunocompetence / Q000502:physiology; D007165:Immunosuppression Therapy / Q000379:methods; D008833:Microcirculation / Q000502:physiology; D010012:Osteogenesis / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D012501:Saphenous Vein / Q000601:surgery; D016038:Skin Transplantation; D014022:Tissue Survival; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
Clin Orthop Relat Res. 1977 Jan-Feb;(122):340-6
837618
Transplant Proc. 1998 Sep;30(6):2754-61
9745561
Plast Reconstr Surg. 1996 Jan;97(1):139-48; discussion 149-51
8532772
J Am Acad Orthop Surg. 2002 May-Jun;10(3):210-6
12041942
N Engl J Med. 1993 Mar 4;328(9):593-602
8429851
Clin Orthop Relat Res. 1996 Mar;(324):86-97
8595781
Microsurgery. 2004;24(3):248-54
15160385
Microsurgery. 1984;5(1):19-23
6369068
Microsurgery. 1999;19(6):289-95
10469445
N Engl J Med. 1988 Mar 17;318(11):689-91
3278235
Circ Res. 1964 Feb;14:164-87
14118761
Plast Reconstr Surg. 1991 Mar;87(3):401-11
1998012
J Hand Surg Am. 1999 May;24(3):586-93
10357540
Microsurgery. 2005;25(5):415-22
16025439
J Reconstr Microsurg. 2001 Oct;17(7):511-7; discussion 518
11598825
Microsurgery. 2004;24(1):85-91
14748033
Clin Orthop Relat Res. 2000 Nov;(380):204-14
11064993
J Orthop Res. 2007 Mar;25(3):370-7
17106873
J Bone Joint Surg Br. 1999 May;81(3):538-44
10872380
J Reconstr Microsurg. 1991 Apr;7(2):101-3
2051430
Handchir Mikrochir Plast Chir. 2001 Jul;33(4):277-82
11518991
Microsurgery. 2007;27(8):657-63
17935153
J Hand Surg Am. 1979 Jan;4(1):23-33
759500
J Reconstr Microsurg. 1988 Apr;4(3):209-15
2455807
Transplant Proc. 2002 Nov;34(7):2722-4
12431586
J Orthop Res. 2008 Jun;26(6):741-5
18186132
J Hand Surg Am. 1995 Nov;20(6):902-14
8583061
Transplantation. 2003 Dec 27;76(12):1662-8
14688512
J Bone Joint Surg Am. 1991 Sep;73(8):1123-42
1890115
Clin Orthop Relat Res. 2005 Sep;438:80-4
16131873
J Bone Joint Surg Am. 1992 Dec;74(10):1441-9
1469003
Plast Reconstr Surg. 1991 Jan;87(1):108-15
1984254
Acta Orthop Scand. 1996 Aug;67(4):389-92
8792745
J Hand Surg Am. 1995 Jan;20(1):77-87
7536766
Transpl Int. 2007 May;20(5):410-8
17274795
Clin Orthop Relat Res. 2005 Nov;440:233-41
16239813
Biometrics. 1984 Sep;40(3):819-25
6518249
J Hand Surg Am. 2000 Sep;25(5):849-59
11040300
Microsurgery. 2009;29(5):379-84
19530087
J Bone Joint Surg Br. 1996 Jul;78(4):652-7
8682837
J Craniomaxillofac Surg. 1996 Aug;24(4):214-23
8880447
J Orthop Res. 2009 Nov;27(11):1514-20
19437510
Transplant Proc. 2000 May;32(3):588-90
10812125
J Neurosurg. 2007 May;106(5):924-8
17542543
J Orthop Res. 2008 Jun;26(6):746-52
18203184
Lancet. 1996 Apr 6;347(9006):970-1
8598781
J Bone Joint Surg Am. 2009 Oct 1;91 Suppl 2:169-83
19805581
Clin Orthop Relat Res. 1996 Mar;(324):233-43
8595762
Transplantation. 1989 Nov;48(5):782-6
2479130
Transplantation. 2002 Dec 15;74(11):1624-30
12490798
Plast Reconstr Surg. 1999 Jul;104(1):161-70
10597689
Clin Orthop Relat Res. 1986 Mar;(204):266-85
3956014
Hand Clin. 1993 Aug;9(3):455-66
8408255